These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 12715720)

  • 1. [New immune suppressants: topical immunomodulatory agents].
    Senatorski G; Sułowicz W; Paczek L
    Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New topical treatment of atopic dermatitis].
    Czarnecka-Operacz M; Silny W
    Pol Merkur Lekarski; 2003 Jun; 14(84):682-4. PubMed ID: 14524304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR
    Semin Cutan Med Surg; 2001 Dec; 20(4):268-74. PubMed ID: 11770914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P; Ellis CN; Girolomoni G
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.
    Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ;
    J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local treatment of atopic dermatitis with calcineurin inhibitors].
    Langeland T
    Tidsskr Nor Laegeforen; 2006 Jan; 126(3):321-2. PubMed ID: 16440040
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic.
    Bekersky I; Lilja H; Lawrence I
    Semin Cutan Med Surg; 2001 Dec; 20(4):226-32. PubMed ID: 11770909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.
    Nghiem P; Pearson G; Langley RG
    J Am Acad Dermatol; 2002 Feb; 46(2):228-41. PubMed ID: 11807435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential new indications of topical calcineurin inhibitors.
    Luger T; Paul C
    Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical calcineurin inhibitors in atopic eczema -- pro].
    Wollenberg A
    Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1614. PubMed ID: 16823713
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M; Jenerowicz D
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.